LIP
AXSM icon

Lighthouse Investment Partners’s Axsome Therapeutics AXSM Stock Holding History

Lighthouse Investment Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
1,549
-3,091
-67% -$534K 0.01% 609
2025
Q4 		$847K Buy
+4,640
New +$648K 0.03% 517
2024
Q1 		– Sell
-56,202
Closed -$4.47M – 378
2023
Q4 		$4.47M Buy
+56,202
New +$3.76M 0.2% 117

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lighthouse Investment Partners's AXSM Position: Q1 2026 in Review

Lighthouse Investment Partners reduced its Axsome Therapeutics (AXSM) stake by 67% in Q1 2026, selling an estimated $534K and leaving 1,549 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #609.

Lighthouse Investment Partners first reported a position in AXSM in Q4 2023 and has held it in 3 quarters since. The position peaked at $4.47M in Q4 2023. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Lighthouse Investment Partners held 1,549 shares of Axsome Therapeutics worth $262K as of Q1 2026.
  • Lighthouse Investment Partners sold 3,091 Axsome Therapeutics shares in Q1 2026, an estimated $534K.
  • Axsome Therapeutics made up 0.01% of Lighthouse Investment Partners's portfolio in Q1 2026, its #609 holding.
  • Lighthouse Investment Partners first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Lighthouse Investment Partners's Axsome Therapeutics position peaked at $4.47M in Q4 2023.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.